• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Real-world insights on heart failure recovery: A missed opportunity in guideline-directed therapy

Real-world insights on heart failure recovery: A missed opportunity in guideline-directed therapy

by Truveta staff | Feb 26, 2025 | Research

Heart failure with reduced ejection fraction (HFrEF) remains a leading cause of morbidity and mortality. While guideline-directed medical therapy (GDMT) has been shown to improve left ventricular ejection fraction (LVEF), real-world data on LVEF recovery and GDMT...
Extracting ejection fraction data from echo reports using AI

Extracting ejection fraction data from echo reports using AI

by Truveta staff | Aug 31, 2023 | Data, Technology

Data captured in electronic health records (EHRs) can provide rich clinical insights about patient journeys and medical histories, gaps in care, treatment outcomes and effectiveness, and more. However, much of this information lies hidden within free-text clinical...
Unlocking real-world data for cardiovascular research: The promise of complete and clean EHR data for drug and device development

Unlocking real-world data for cardiovascular research: The promise of complete and clean EHR data for drug and device development

by Truveta staff | Jun 20, 2023 | Technology

The Centers for Disease Control and Prevention reports that cardiovascular (CV) disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the US, with 805,000 dying yearly.   Developing improved cardiovascular therapies is...

Share this


Recent posts

  • Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers
  • Top 5 takeaways from Truveta Symposium 2025
  • Women’s health: Pain medication remains rare for women receiving IUDs

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Get started

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Interested in learning more?

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice